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Standardization of toxin preparations derived from Bacillus thuringiensis (Berliner) used in laboratory
bioassays is critical for accurately assessing possible changes in the susceptibility of field populations of target
pests. Different methods were evaluated to quantify Cry1Ab, the toxin expressed by 80% of the commercially
available transgenic maize that targets the European corn borer, Ostrinia nubilalis (Hübner). We compared
three methods of quantification on three different toxin preparations from independent sources: enzyme-linked
immunosorbent assay (ELISA), sodium dodecyl sulfate-polyacrylamide gel electrophoresis and densitometry
(SDS-PAGE/densitometry), and the Bradford assay for total protein. The results were compared to those
obtained by immunoblot analysis and with the results of toxin bioassays against susceptible laboratory colonies
of O. nubilalis. The Bradford method resulted in statistically higher estimates than either ELISA or SDS-
PAGE/densitometry but also provided the lowest coefficients of variation (CVs) for estimates of the Cry1Ab
concentration (from 2.4 to 5.4%). The CV of estimates obtained by ELISA ranged from 12.8 to 26.5%, whereas
the CV of estimates obtained by SDS-PAGE/densitometry ranged from 0.2 to 15.4%. We standardized toxin
concentration by using SDS-PAGE/densitometry, which is the only method specific for the 65-kDa Cry1Ab
protein and is not confounded by impurities detected by ELISA and Bradford assay for total protein. Bioassays
with standardized Cry1Ab preparations based on SDS-PAGE/densitometry showed no significant differences in
LC50 values, although there were significant differences in growth inhibition for two of the three Cry1Ab
preparations. However, the variation in larval weight caused by toxin source was only 4% of the total variation,
and we conclude that standardization of Cry1Ab production and quantification by SDS-PAGE/densitometry
may improve data consistency in monitoring efforts to identify changes in insect susceptibility to Cry1Ab.
Transgenic plants expressing toxins from Bacillus thuringiensis
(Berliner) (Bt plants) have high efficacy against target pests
and represent an important alternative to conventional insec-
ticides. However, the widespread use of this technology has
generated concerns due to the potential for increased selection
intensity and because insect resistance to B. thuringiensis for-
mulations has already been reported both in the laboratory
(13, 19) and among populations of target pests where B.
thuringiensis formulations have been used in a pest manage-
ment setting (8, 13, 20).
To prevent or at least reduce the rate of resistance devel-
opment to Bt plants in target pest species, the U.S. Environ-
mental Protection Agency has imposed rigorous regulatory
requirements that mandate certain practices related to resis-
tance management (1). One of the primary requirements for
registration includes monitoring susceptibility of field popula-
tions of target pests to verify potential changes in susceptibility
to Cry toxins (22). Maize, Zea mays L., expressing Cry toxins
comprises 40% of the total area of maize production in United
States (21), and Cry1Ab is the toxin expressed by 80% of the
commercially available transgenic maize that targets the Eu-
ropean corn borer, Ostrinia nubilalis (Hübner). Although sus-
ceptibility to Cry1Ab has been monitored since 1995, differ-
ences between batches of fermentation products or between
formulated Bt insecticides and purified toxins have led to in-
consistency in the measured bioactivity (B. D. Siegfried, un-
published). This inconsistency complicates the assessment of
changes in insect susceptibility as estimated by 50% lethal
concentration (LC50) values generated by probit mortality
curves or diagnostic concentrations (18). Differences in the
bioactivity of Cry1Ab have been attributed to impurity of
batches and to the lack of standardized protocols for Cry1Ab
production and quantification.
Several methods have been used to quantify Cry1Ab, includ-
ing enzyme-linked immunosorbent assay (ELISA), sodium do-
decyl sulfate-polyacrylamide gel electrophoresis–densitometry
(SDS-PAGE/densitometry), and total protein assays such as
the Bradford assay. The latter two methods have been used to
obtain relative estimates of Cry1Ab concentration (3, 4, 15).
However, there has been limited information regarding condi-
tions used during determinations of Cry1Ab concentration,
and differences among protocols for Cry1Ab production may
lead to inconsistent bioassay results. Moreover, estimates in-
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volving the Bradford assay may be affected by protein impuri-
ties and nonprotein components (2), and several factors may
affect the estimates of protein concentration determined by
SDS-PAGE/densitometry, including the reducing agent used
to denature proteins, fixing solutions, and staining and destain-
ing procedures (10, 14).
To assure accurate assessment of susceptibility to Cry1Ab
using insect bioassays, it is critical to establish technical spec-
ifications for protocols used to quantify different Cry1Ab prep-
arations. The objective of the present research was to evaluate
and compare different methods of Cry1Ab quantification
based on the precision and relative ability to estimate Cry1Ab
in batches obtained from independent sources. To determine
the accuracy of quantification methods, we also assessed the
susceptibility of O. nubilalis neonates to different Cry1Ab
batches by using standard bioassay techniques.
MATERIALS AND METHODS
Cry1Ab sources. (i) Cry1Ab from the University of Nebraska, Lincoln (UNL).
The Cry1Ab gene was expressed in Escherichia coli host strain JM103 by using
the expression vector pKK223-3. The E. coli strain was provided by the Bacillus
Genetic Stock Center (http://www.bgsc.org/). Cry1Ab protoxin was obtained
from E. coli fermentation products by a modification of the method described by
Lee et al. (11). The solubilized protein was digested with bovine pancreatic
trypsin, and insoluble material was removed by centrifugation. The Cry1Ab
preparation was dialyzed against 50 mM sodium carbonate-sodium bicarbonate
buffer (pH 10.0) by using a 10,000 MW Slide-A-Lyzer dialysis cassette (Pierce
Chemical, Rockford, IL).
(ii) Cry1Ab from Auburn University (AU). Cry1Ab protoxin was expressed in
the XL1-Blue strain of E. coli as a single gene product using plasmid pBD-140
(provided by R. A. deMaagd, Plant Research International, Wageningen, The
Netherlands). Inclusion bodies containing Cry1Ab protoxin were dissolved and
treated with trypsin, and the activated Cry1Ab toxin was isolated by using high-
performance liquid chromatography (16). Purified Cry1Ab toxin was desalted,
lyophilized, and stored at 80°C. Prior to bioassays, the protein was solubilized
in 50 mM sodium carbonate buffer (pH 10.0) at 37°C and then vortex mixed until
small particles were no longer visible.
(iii) Cry1Ab from Monsanto Company (St. Louis, MO). The Cry1Ab was
purified from a spore-crystal paste produced by fermentation of B. thuringiensis
subsp. kurstaki. The full-length Cry1Ab protein was solubilized at a high pH in
the presence of reducing agent and protease inhibitors at 4°C. The soluble
protein was treated with bovine pancreatic trypsin at 4°C until ca. 90% was
converted to the trypsin-resistant core protein, which was purified in a 1.2-liter Q
Sepharose FastFlow column. The trypsin-resistant core protein was eluted as a
single symmetrical peak by using a gradient of sodium chloride. Peak fractions
were pooled and dialyzed against 50 mM carbonate-bicarbonate buffer (pH
10.25) with 50 mM sodium chloride.
Quantification methods. (i) Bradford assay. The Bradford assay has been
reported to exhibit slight nonlinearity in the absorbance response, which is
attributed to an overlap in the spectrum of the two different color forms of the
dye (2). Therefore, the Cry1Ab concentration estimates were determined by
using the range of standard concentrations that provides a linear response be-
tween 0 and 600 g of protein/ml. Bovine serum albumin (BSA), standard grade
at 2,000 g/ml (Pierce Chemical), was diluted in 50 mM sodium carbonate-
sodium bicarbonate buffer (pH 10.0) according to the manufacturer’s instruc-
tions. The concentrations of standards were 25, 125, 250, and 500 g/ml. Absor-
bance readings at 595 nm were determined with a microplate reader (Becton
Dickinson Labware, Franklin Lakes, NJ) after duplicates of standards and un-
knowns had been incubated for 10 min with Coomassie G-250 dye (Coomassie
Plus; Pierce Chemical). Determinations were replicated at least four times for
each preparation. The Coomassie Plus reagent was at room temperature before
incubation with standards and unknowns.
(ii) ELISA. The Bt-Cry1Ab/Cry1Ac ELISA kit was obtained from Abraxis
(Warminster, PA) and stored at 4°C before use. Unknowns were diluted in
sample extraction-dilution buffer provided with the kit. Centrifuge tubes (1.5 ml)
were used to prepare 1-ml dilutions. Cry1Ab batches were diluted to achieve a
total dilution factor of 200,000, which was necessary to fit unknown Cry1Ab
concentrations into the range of standards provided with the kit (0.0 to 4.0
ng/ml). The kit is provided with removable strips containing eight wells each.
Determinations were performed in two strips where a blank, four Cry1Ab stan-
dards, and three diluted Cry1Ab samples were assayed in duplicate. The dilution
buffer and other kit components were at room temperature 30 min before assays.
Blanks, Cry1Ab standards, diluted Cry1Ab preparations, and reagents were
taken from vials and placed into PCR cap strips before being transferred into
ELISA strips. Volumes were transferred to ELISA strips with a multichannel
pipette to ensure the same incubation time in each well. Determinations were
replicated at least three times. Incubation and washing steps were done accord-
ing to the manufacturer’s instructions.
(iii) SDS-PAGE/densitometry. As a reference for protein quantification, BSA
(98%, ELISA grade; Sigma-Aldrich) was diluted to 600, 400, 267, 178, and 119
g/ml in 50 mM sodium carbonate-sodium bicarbonate buffer (pH 10.0), with
phenylmethylsulfonyl fluoride at 0.5 mM to minimize protein degradation. The
concentrations were selected to prevent excessive protein loading, which reduces
the sharpness of bands. BSA has a high content of cysteine residues and may
undergo oxidation during electrophoresis (10), which also reduces the sharpness
of the bands and ultimately compromises the quantification of band volume and
intensity. To prevent oxidation during electrophoresis, BSA and Cry1Ab proteins
were denatured by reduction-alkylation (10). Standards and samples (5 l each)
were mixed with 10 l of Laemmli sample buffer (Bio-Rad, Hercules, CA)
containing 5 mM dithiothreitol and denatured for 3 min at 90°C. Iodacetamide
was added to make the final concentration 12.5 mM on samples and standards
and incubated at 90°C for 1 min. Standards and samples of the three Cry1Ab
batches were then immediately subjected to SDS-PAGE in 12% polyacrylamide
Tris-HCl Ready Gels (Bio-Rad) for 2 h at 80 V and ambient temperature. This
polyacrylamide percentage provides little background staining with Brilliant Blue
G-colloidal stain (14). Gels were replicated four times. After electrophoresis,
gels were washed for 30 s in double-distilled water to eliminate electrode buffer.
Before staining, gels were fixed in 12% trichloroacetic acid and 3.5% 5-sulfosali-
cyclic acid (Sigma-Aldrich). After 30 min, gels were rinsed with double-distilled
water and stained in 50 ml of staining suspension containing 0.1% (wt/vol)
Brilliant Blue G, 0.29 M phosphoric acid, and 16% saturated ammonium sulfate
(Sigma-Aldrich) for 2 h and then rinsed in 10% acetic acid in 25% (vol/vol)
methanol for 30 s with shaking. Gels were then rinsed with 25% methanol three
times to remove acetic acid and destained in 25% methanol for up to 24 h. After
destaining for at least 1 h, the gels were photographed by using Gel Doc 2000
documentation system (Bio-Rad). Each photograph was analyzed densitometri-
cally with Quantity One 4.2.3. software (Bio-Rad).
Statistical analysis. The precision of each quantification method was com-
pared based on the calculated coefficient of variation for concentration estimates
obtained for each Cry1Ab batch. To test whether quantification methods gen-
erated different estimates of Cry1Ab concentration, the three methods were
compared in a randomized block design with subsampling. Each independent
Cry1Ab batch was considered a block, and the average amount of Cry1Ab
quantified by each method was compared across all batches. Therefore, the main
factor in the analysis was the quantification method used to quantify the three
Cry1Ab batches. The data were first tested for normality by the methods of
Shapiro-Wilk and the normal probability plots using the PROC UNIVARIATE
procedure of the SAS software (version 9.1; SAS Institute, Inc., Cary, NC). The
data were further analyzed with a one-way analysis of variance using the PROC
MIXED procedure, and treatment means were separated by using LSMEANS
tests at   0.05.
Validation of quantification results. (i) Immunoblotting with anti-Cry1Ab.
Immunoblot analysis was used to test for Cry1Ab-related impurities and to
determine whether small quantities of Cry1Ab generate similar signal intensities.
Cry1Ab concentrations were standardized based on SDS-PAGE/densitometry
results. Duplicates of standardized concentrations of each Cry1Ab batch (200 ng)
were separated by SDS-PAGE as described previously (9), electroblotted onto
polyvinylidene difluoride (PVDF) membrane (Bio-Rad) for 90 min using a Mini
Trans-Blot electrophoretic transfer cell (Bio-Rad), and blocked for 2 h at room
temperature with phosphate-buffered saline (pH 8.0) containing 5% nonfat dry
milk powder, 5% glycerol, and 0.5% Tween 20. The PVDF membrane was
incubated with polyclonal rabbit anti-Cry1Ab (1:2,500; provided by the Mon-
santo Company), washed three times, and then incubated with goat anti-rab-
bit-AP (1:10,000) and washed three times with blocking buffer. The PVDF
membrane was washed with assay buffer (Tropix, Inc., Bedford, MA), and de-
tection was performed with the CDP-Star chemiluminescence kit (Tropix, Inc.).
The membranes were then washed, exposed to Kodak BioMax film (Eastman
Kodak, Rochester, NY), and developed according to the manufacturer’s instruc-
tions. Films were photographed by using Gel Doc 2000 documentation system
(Bio-Rad) and analyzed densitometrically by using Quantity One 4.2.3. software
(Bio-Rad) as described previously.
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(ii) Insect strains and bioassay. The three Cry1Ab batches were tested against
two susceptible strains of European corn borer. One strain originated in 2005
from a field collection of 900 individuals from Iowa and Nebraska and was
reared for 10 generations before bioassays (F10). The second strain originated
from a field collection of 500 individuals from the Lombardia region of north-
ern Italy and has been reared in the absence of selection for more than 100
generations (F100). Bioassay methods described by Marçon et al. (12) were used
to test the effectiveness of the three different Cry1Ab batches previously de-
scribed with each quantified based on SDS-PAGE/densitometry. Neonate larvae
(24 h after eclosing) were exposed to seven concentrations of each Cry1Ab
toxin (0.1, 0.3, 0.9, 2.7, 8.0, 24.0, and 72.0 ng/cm2). Each toxin was tested in four
replicates in two separate dilutions which were prepared using 0.1% Triton
X-100 nonionic detergent to obtain uniform spreading over the diet surface.
Dilutions were tested on two different dates, and 512 insects in total were tested
for each toxin-strain combination. Mortality and larval weights were recorded
after 7 days. Concentration-mortality curves for each toxin-strain combination
was obtained by probit analysis (5) using POLO-PC (LeOra Software, Berkeley,
CA). Larval weights were transformed to percent growth inhibition relative to
the controls, and these data were analyzed by nonlinear regression fitted to a
probit model (12).
To verify the relative importance of variation associated with the use of
different toxin sources, we conducted a hierarchical analysis of variance (PROC
NESTED) using SAS software (version 9.1; SAS Institute) to quantify variance
components associated with the inhibitory response of larvae exposed to two
Cry1Ab concentrations (0.3 and 0.9 ng/cm2). Larval weight after 7 days was used
to estimate variance components associated with toxin source, dilution, strain,
and day. We used a balanced design where 16 larvae were tested per toxin-
dilution-strain-day combination. The weight of larva exposed to diet treated with
0.1% Triton X-100 nonionic detergent was used as a control.
RESULTS
Quantification methods. Significant differences in Cry1Ab
concentration-estimates were detected among the three meth-
ods of quantification (F  5.64, df  61, P  0.0057). A
comparison across all toxin sources showed that the Bradford
assay produced statistically higher estimates (365.57 	 9.00)
than the ELISA (321.44 	 10.69; t  3.16, df  61, P  0.0025)
and SDS-PAGE/densitometry (328.26 	 15.12; t  2.12, df 
61, P  0.0381). There were no significant differences detected
between estimates obtained by ELISA and SDS-PAGE/densi-
tometry (t  0.37, df  61, P  0.7137). The average con-
centration and coefficient of variation (CV) estimated for the
three methods tested are presented in Table 1. For two
Cry1Ab batches (UNL and Monsanto Company), the concen-
tration estimates determined by ELISA were higher than the
concentration estimates determined by SDS-PAGE/densitom-
etry. The Bradford assay showed the lowest CVs for estimates
of Cry1Ab concentration, which ranged from 2.4 to 5.4%. The
CV of estimates obtained by ELISA ranged from 12.8 to
26.5%, whereas the CV of estimates obtained by SDS-PAGE/
densitometry ranged from 0.2 to 15.4%. These results indicate
that ELISA exhibited the lowest precision among the three
methods tested.
Western blot with Cry1Ab batches. A Western blot of the
Cry1Ab proteins from three independent preparations is
shown in Fig. 1. Cry1Ab quantities were normalized based on
SDS-PAGE/densitometry results, and the relative intensity of
truncated Cry1Ab (65 kDa) was similar across all batches
tested. The Cry1Ab antiserum also recognized peptide resi-
dues that were both larger and smaller in molecular mass than
truncated Cry1Ab. The batch from UNL showed a faint band
above 65 kDa. The number and intensity of bands 65 kDa
indicates that toxins were different in Cry1Ab-related impuri-
ties.
Effectiveness of different Cry1Ab batches. Results of Cry1Ab
bioassays with O. nubilalis strains exposed to three different
preparations of Cry1Ab are presented in Table 2. For the F10
strain, the Cry1Ab LC50 values ranged from 6.1 ng/cm
2 (Mon-
santo) to 9.4 ng/cm2 (AU). For the F100 strain, the Cry1Ab
LC50 values ranged from 4.8 ng/cm
2 (UNL) to 6.0 ng/cm2
(AU). There were no significant differences in LC50 values
among Cry1Ab batches for each insect colony. However, com-
parisons of growth inhibition of both European corn borer
strains indicate that 50% effective concentration (EC50) values
obtained with Cry1Ab from AU were significantly higher (F10,
0.73 ng/cm2; F100, 0.69 ng/cm2) than the EC50 values obtained
with Cry1Ab from UNL (F10, 0.43 ng/cm2; F100, 0.45 ng/cm2)
(Fig. 2).
Variance components. The hierarchical analysis of variance
allowed quantification of the contribution of each factor for
the entire variation in larval weight. Estimates of variance
components for weights of larvae grown with an artificial diet
treated with 0.3 and 0.9 ng of Cry1Ab/cm2 are presented in
Table 3. The control treatment indicated that 75% of the
variation in larval weight is associated with the bioassay
method. Similar variation also was observed at both Cry1Ab
concentrations tested. The toxin source was responsible for ca.
FIG. 1. Immunoblot analysis of three Cry1Ab batches. Lane 1,
batch from UNL; lane 2, batch from Monsanto Company; lane 3, batch
from AU. Proteins (200 ng) were loaded in each lane based on SDS-
PAGE/densitometry quantification. Values indicate the volumes of
65-kDa Cry1Ab bands expressed as optical density multiplied by area
in mm2 (	 standard error) detected by antibody.
TABLE 1. Cry1Ab content in different sources obtained by three
quantification methods
Toxin source Method Cry1Ab concn(g/ml) 	 SE CV (%)
University of Nebraska Bradford 409.8 	 6.1 4.5
ELISA 311.4 	 29.2 26.5
SDS-PAGE/densitometry 279.3 	 8.0 5.7
Auburn University Bradford 315.3 	 2.6 2.4
ELISA 293.7 	 12.8 10.6
SDS-PAGE/densitometry 369.9 	 28.5 15.4
Monsanto Company Bradford 365.9 	 5.3 5.4
ELISA 352.3 	 16.0 12.8
SDS-PAGE/densitometry 338.1 	 0.4 0.2
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4% of the variation in larval weight. The variation caused by
toxin at 0.9 ng/cm2 was significant at a P value of 0.05.
Dilution and strain did not contribute significantly to variabil-
ity in bioassay results. In contrast, the date of the assay was an
important factor affecting variability in larval weight, causing
ca. 20% of the total variation.
DISCUSSION
The results of this investigation provide a basis for establish-
ing standardized methods for quantifying B. thuringiensis toxins
among different preparations. In general, all three methods
provided relatively consistent estimates of Cry1Ab concentra-
tion, but each technique had characteristics that limited accu-
rate quantification of Cry1Ab preparations. The generally
higher estimates obtained with the Bradford assay were not
unexpected because the toxins tested were not 100% pure (Fig.
3). Although this method generally showed the highest preci-
sion, the presence of other proteins and peptide degradation
products could compromise quantification estimates (2).
Our results indicate relatively high variation in estimates of
Cry1Ab concentrations obtained by ELISA. Because ELISA
kits are designed for the detection and quantification of trace
amounts of toxin, a 200,000-fold dilution of stock solutions was
necessary to obtain concentrations within the range of the
standards used to generate standard curves. As a consequence,
slight dilution errors may have caused higher variation in the
concentration estimates (7). Although our study did not indi-
cate significant differences between concentration estimates
obtained by ELISA and SDS-PAGE/densitometry, the reac-
tion of Cry1Ab antiserum with Cry1Ab-related impurities may
also reduce the accuracy of estimates by ELISA. Western blots
of the different Cry1Ab batches revealed immunologically re-
active peptides other than the truncated Cry1Ab protein (Fig.
1), which could result in overestimates of Cry1Ab concentra-
tion. Concentration estimates obtained by SDS-PAGE/densi-
tometry showed consistently lower CV’s than ELISA (Table 1).
This method uses aliquots taken directly from Cry1Ab stocks
reducing errors caused by sample dilution. Moreover, SDS-
PAGE/densitometry also allows quantification of specific pro-
tein bands of interest, eliminating interference of immunolog-
ically reactive Cry1Ab residues.
Although LC50 values were not significantly different among
Cry1Ab batches, the EC50 values obtained with Cry1Ab from
AU were 1.6-fold higher than the EC50 values obtained with
FIG. 2. Growth inhibition (EC50 values with 95% confidence inter-
vals) of two susceptible European corn strains for three Cry1Ab batch-
es: UNL, AU, and Monsanto Company.
TABLE 2. Susceptibility of two European corn borer populations to Cry1Ab toxins from three independent sources
Source and strain No. ofinsects Slope 	 SE
Susceptibility (95% FL)a

2 (df)
LC50 LC90
University of Nebraska
F10 446 3.78 	 0.49 7.4 (6.2–8.6) 16.3 (13.2–22.0) 0.8 (4)
F100 384 2.60 	 0.25 4.8 (4.0–5.8) 15.0 (11.8–20.9) 0.2 (3)
Auburn University
F10 319 2.57 	 0.30 9.4 (4.7–15.8) 29.7 (17.3–113.5) 2.4 (2)
F100 447 2.11 	 0.18 6.0 (4.2–8.7) 24.3 (15.5–49.8) 6.1 (4)
Monsanto Company
F10 383 2.07 	 0.20 6.1 (3.5–9.9) 25.5 (15.1–61.5) 4.5 (3)
F100 384 2.62 	 0.25 5.6 (4.6–6.7) 17.3 (13.5–24.1) 2.2 (3)
a Expressed as nanograms of Cry1Ab/cm2 of artificial diet. FL, fiducial limits.
TABLE 3. Source of variation in weight of European corn borer
larvae growing in artificial diet untreated and treated with Cry1Ab
toxins from different sources
Treatment group and
source of variation df s
2 F ratio P % Variationa
Control (untreated)
Strain 11 0.00 0.20 0.9938 0.00
Day 12 22.87 6.42 0.0001 25.31†
Error 360 67.48 74.69
Treated (Cry1Ab,
0.3 ng/cm2)
Toxin 2 2.97 2.24 0.2537 3.67
Dilution 3 1.34 1.39 0.3345 1.65
Strain 6 0.00 0.82 0.5735 0.00
Day 12 12.78 4.20 0.0001 15.77†
Error 360 63.96 78.92
Treated (Cry1Ab,
0.9 ng/cm2)
Toxin 2 1.91 9.76 0.0486 3.88*
Dilution 3 0.03 1.08 0.4253 0.07
Strain 6 0.00 0.14 0.9882 0.00
Day 12 9.27 4.91 0.0001 18.86†
Error 360 37.94 77.19
a , significant at P  0.05; †, significant at P  0.01.
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Cry1Ab from UNL for both strains tested (Fig. 2). A study with
three European corn borer populations from Germany indi-
cated that two toxin batches caused a ninefold difference in
LC50 values, although the Cry1Ab concentrations of the dif-
ferent batches were not compared before bioassays (18). These
results suggest that Cry1Ab sources may cause pseudovariation
in susceptibility whenever a new Cry1Ab batch is introduced.
Such variation may decrease the sensitivity and reliability of
monitoring efforts and lead to an incorrect assessment of nat-
ural variation.
The potency of insecticides is often measured by LC50 and
EC50 estimates because the tolerance distribution is symmet-
rical for all populations. However, potency comparisons using
EC50 estimates that are based on the weights of exposed sub-
jects are more useful to identify the relative potency of toxic
preparations. Because larval weight is a continuous variable, it
more accurately reflects the relationship between the dose
transferred and the magnitude of the response (6). Therefore,
LC50 estimates are less sensitive than EC50 estimates for de-
tecting small differences in potency of Cry1Ab toxins, as shown
in the present study.
Natural variation in European corn borer susceptibility, er-
rors in Cry1Ab quantification, difficulties in the solubilization
of lyophilized Cry1Ab preparations, or inherent differences in
the toxicity of Cry1Ab batches may contribute to variation in
EC50 values obtained in bioassays. Moreover, bioassay meth-
ods are associated with a degree of variation caused by other
factors, including cohort, dilution, or environmental conditions
(6, 17). The strains tested had similar susceptibilities to
Cry1Ab, and the hierarchical analysis of variance did not reveal
a significant variance for the strain component (Table 3). This
result was not unexpected because both strains showed a sim-
ilar degree of genetic variability in response to Cry1Ab toxins,
which is indicated by the similarity among slopes and LC50
values of probit mortality curves (Table 2). The 20% varia-
tion associated with bioassay data is likely explained by slight
differences in environmental conditions or, more importantly,
differences in cohorts used in bioassays. Interestingly, the toxin
batch was responsible for only 4% variation in larval weight,
which indicates the importance of the standardization methods.
Comparisons of EC50 values indicate that the Cry1Ab prep-
aration from Auburn University exhibited slightly lower poten-
cies than the other preparations tested. This reduced bioactiv-
ity may be related to incomplete solubilization because this was
the only preparation to be lyophilized after purification. Com-
parisons among bioassays with Heliothis virescens (Fabricius)
and Helicoverpa zea (Boddie) (Lepidoptera: Noctuidae) at dif-
ferent laboratories using a single Cry1Ac batch indicate that
solubilization of lyophilized Cry1Ac preparations can intro-
duce variation in bioassays (W. J. Moar, unpublished results).
The methods described here provide a starting point for
developing methods to standardize different B. thuringiensis
toxin preparations. Quantification involving SDS-PAGE/den-
sitometry provides a means to determine the purity and stan-
dardize the concentrations among different Cry1Ab prepara-
tions. Bioassays using well-established susceptible insect
strains can be used to further validate determinations of con-
centrations among different preparations (18). Moreover, the
methods provide means to determine whether degradation
during long-term storage at 80°C has caused a reduction in
Cry1Ab bioactivity over time.
The present study is the first report of bioassays with Cry1Ab
preparations produced and purified at independent laborato-
ries showing similar bioactivity toward susceptible insects. Be-
cause the batches were obtained using different fermentation
protocols and because we were able to identify small variations
caused by toxin source, we conclude that standardization of
Cry1Ab production and quantification may improve data con-
sistency in monitoring efforts to identify changes in suscepti-
bility of target pests to Cry1Ab toxin from B. thuringiensis.
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